Company logo

HIMS - Hims & Hers Health, Inc.

NYSE -> Consumer Defensive -> Household & Personal Products
San Francisco, United States
Type: Equity

HIMS price evolution
HIMS
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $130.15 $106.09 $97.52
Short term investments $98 $98.36 $124.32
Net receivables $4.57 $5.55 $5.71
Inventory $49.11 $40.59 $29.83 $22.46
Total current assets $326.38 $290.92 $261.73 $265.05
Long term investments
Property, plant & equipment $63.03 $60.57 $56.63 $45.73
Goodwill & intangible assets $128.01 $128.74 $129.46
Total noncurrent assets $189.58 $186.37 $176.13
Total investments $98 $98.36 $124.32
Total assets $602.26 $480.5 $448.11 $441.19
Current liabilities
Accounts payable $75.44 $57.1 $43.92 $43.07
Deferred revenue $20.99 $13.73 $7.73
Short long term debt $1.63 $1.54 $1.28
Total current liabilities $152.65 $108.67 $93.32 $88.47
Long term debt $9.84 $10.28 $8.67
Total noncurrent liabilities $9.86 $10.3 $8.69
Total debt $11.47 $11.82 $9.95
Total liabilities $162.21 $118.53 $103.62 $97.16
Shareholders' equity
Retained earnings -$268.16 -$343.75 -$357.05 -$368.18
Other shareholder equity $0.23 -$0.17 -$0.16 -$0.12
Total shareholder equity $361.97 $344.48 $344.03
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $97.52 $47.63 $72.64 $27.34
Short term investments $124.32 $132.85 $175.49 $72.86
Net receivables $5.71 $3.2 $3.58
Inventory $22.46 $21.6 $13.56 $3.54
Total current assets $265.05 $216.6 $269.9 $113.08
Long term investments
Property, plant & equipment $45.73 $16.1 $5.11
Goodwill & intangible assets $129.46 $132.72 $136.77
Total noncurrent assets $176.13 $149.75 $150.68 $5.61
Total investments $124.32 $132.85 $175.49 $72.86
Total assets $441.19 $366.3 $420.58 $118.7
Current liabilities
Accounts payable $43.07 $32.4 $19.64 $8.07
Deferred revenue $7.73 $1.47 $3.19 $1.27
Short long term debt $1.28 $1.66 $1.36
Total current liabilities $88.47 $47.9 $79.22 $15.23
Long term debt $8.67 $3.65 $4.12
Total noncurrent liabilities $8.69 $6.66 $6.75 $0.38
Total debt $9.95 $5.31 $5.48
Total liabilities $97.16 $54.6 $85.97 $15.61
Shareholders' equity
Retained earnings -$368.18 -$344.6 -$278.95 -$171.29
Other shareholder equity -$0.12 -$0.3 -$0.14 -$0.01
Total shareholder equity $344.03 $311.74 $334.62 -$146.87
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $401.56 $315.65 $278.17 $246.62
Cost of revenue $59.03 $49.08 $42.56
Gross Profit $317.89 $256.61 $229.09 $204.06
Operating activities
Research & development $18.65 $15.32 $13.4
Selling, general & administrative $185.48 $165.12 $158.21
Total operating expenses $294.65 $245.58 $219.19 $204.46
Operating income $11.03 $9.9 -$0.4
Income from continuing operations
EBIT $13.42 $12.4 $2.2
Income tax expense -$51.99 $0.13 $1.27 $0.95
Interest expense $2.64
Net income
Net income $75.59 $13.3 $11.13 $1.25
Income (for common shares) $13.3 $11.13 $1.25
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $872 $526.92 $271.88 $148.76
Cost of revenue $157.05 $118.19 $67.38 $39.31
Gross Profit $714.95 $408.72 $204.49 $109.45
Operating activities
Research & development $48.23 $29.24
Selling, general & administrative $576.32 $370.78 $319.54 $124.59
Total operating expenses $744.4 $477.42 $319.54 $124.59
Operating income -$29.45 -$68.7 -$115.04 -$15.14
Income from continuing operations
EBIT -$21.57 -$65.71 -$110.8 -$17.98
Income tax expense $1.98 -$0.03 -$3.14 $0.13
Interest expense $0.01
Net income
Net income -$23.55 -$65.68 -$107.66 -$18.11
Income (for common shares) -$23.55 -$65.68 -$107.66 -$18.11
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $13.3 $11.13 $1.25
Operating activities
Depreciation $4.29 $3.58 $3.17
Business acquisitions & disposals
Stock-based compensation $24.04 $19.03 $17.79
Total cash flows from operations $53.59 $25.84 $21.98
Investing activities
Capital expenditures -$6.03 -$13.96 -$11.2
Investments $1.56 $27 $31.89
Total cash flows from investing -$1.84 -$4.47 $13.04 $20.7
Financing activities
Dividends paid
Sale and purchase of stock -$6.91 -$22.99 $0.03
Net borrowings
Total cash flows from financing -$94.19 -$25.07 -$30.31 -$3.96
Effect of exchange rate $0.19 -$0 $0 -$0.05
Change in cash and equivalents $68.86 $24.06 $8.57 $38.67
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$23.55 -$65.68 -$107.66 -$18.11
Operating activities
Depreciation $11.44 $9.08 $5.58 $1.06
Business acquisitions & disposals -$0.46 -$46.47
Stock-based compensation $66.08 $42.82 $67.21 $5.83
Total cash flows from operations $73.48 -$26.53 -$34.41 -$2.48
Investing activities
Capital expenditures -$26.49 -$7.25 -$5.01 -$4.23
Investments $14.39 $42.41 -$104.79 -$35.47
Total cash flows from investing -$12.11 $34.7 -$156.27 -$39.7
Financing activities
Dividends paid
Sale and purchase of stock $2.62 $3.42 $252.7 $0.68
Net borrowings $1.19 -$1.51
Total cash flows from financing -$11.47 -$33.13 $235.04 $47.74
Effect of exchange rate -$0.01 -$0.05 -$0.07 -$0.01
Change in cash and equivalents $49.89 -$25.01 $44.29 $5.55
Fundamentals
Market cap $13.17B
Enterprise value N/A
Shares outstanding 217.82M
Revenue $1.24B
EBITDA N/A
EBIT N/A
Net Income $101.26M
Revenue Q/Q 77.13%
Revenue Y/Y 56.70%
P/E ratio 130.08
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 10.60
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS $0.46
ROA 20.54%
ROE N/A
Debt/Equity 0.28
Net debt/EBITDA N/A
Current ratio 2.14
Quick ratio 1.82